Brief: Nevro Announces FDA Approval For Expanded Labeling Of 10 KHZ High Frequency Spinal Cord Stimulation System
19/01/2022 12:10
Jan 19 (Reuters) - Nevro Corp NVRO.N :
* NEVRO ANNOUNCES FDA APPROVAL FOR EXPANDED LABELING FOR ITS
10
KHZ HIGH FREQUENCY SPINAL CORD STIMULATION SYSTEM FOR TREATMENT
OF NON-SURGICAL REFRACTORY BACK PAIN (NSRBP)
Source text for Eikon: ID:nPnb3GwG3a
Further company coverage: NVRO.N
Recent news on Nevro
See all newsNevro Corp reports results for the quarter ended December 31 - Earnings Summary
Nevro Corp expected to post a loss of 77 cents a share - Earnings Preview
Nevro Corp expected to post a loss of 77 cents a share - Earnings Preview
Nevro Corp expected to post a loss of 78 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Altus Power, Amazon, Nevro